Cost-effectiveness of universal genetic screening for familial hypercholesterolemia in young adults aged 18–40 years in China
Universal FH genetic screening in young adults has the potential to be cost-effective in China, compared to current passive screening strategy and universal cholesterol screening strategy. Performing screening in younger age would result in better cost-effectiveness benefit.
Authors
- Fenghao Shi
- Lingqin Song (ORCID: https://orcid.org/0000-0002-5810-6313)
- Mingwang Shen (ORCID: https://orcid.org/0000-0003-4553-800X)
- Chao Li (ORCID: https://orcid.org/0000-0003-1058-4153)
- Lei Zhang (ORCID: https://orcid.org/0000-0003-2343-084X)
- Jinyan Wang (ORCID: https://orcid.org/0000-0002-3628-9761)
- Rui Meng (ORCID: https://orcid.org/0000-0003-1165-9612)
- Baoming Zhang (ORCID: https://orcid.org/0009-0006-9632-3120)
Institutions
- Peking University (CN)
- North Minzu University (CN)
- Melbourne Sexual Health Centre (AU)
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
- Alfred Health (AU)
- Monash University (AU)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- BMC Medicine
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1186/s12916-025-03966-7
- Citations
- 3
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 6.02
Funders
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
- National Key Research and Development Program of China